Use of Enoxaparin in Patients with Chronic Kidney Disease Donald F. BrophyDomenic A. Sica Commentary 03 January 2013 Pages: 991 - 994
Benefit-Risk Assessment of Drotrecogin Alfa (Activated) in the Treatment of Sepsis Daniel De Backer Review Article 03 January 2013 Pages: 995 - 1010
Drug-Induced Skin, Nail and Hair Disorders Laurence Valeyrie-AllanoreBruno SassolasJean-Claude Roujeau Review Article 03 January 2013 Pages: 1011 - 1030
Adverse Drug Reactions in Patients with Phaeochromocytoma Graeme EisenhoferGraham RiversKarel Pacak Review Article 03 January 2013 Pages: 1031 - 1062
Drug Interactions with Cholinesterase Inhibitors Neda TavassoliAgnes SommetJean-Louis Montrastruc Original Research Article 03 January 2013 Pages: 1063 - 1071
Factors that Influence Under-Reporting of Suspected Adverse Drug Reactions among Community Pharmacists in a Spanish Region Marta IrujoGuadalupe BeitiaBerta Lasheras Original Research Article 03 January 2013 Pages: 1073 - 1082